Group 1 - The core point of the article highlights the recent trading activity of southbound funds in Jinxin Reproductive Medicine (01951.HK), indicating a reduction in holdings on November 12, 2025, by 4.375 million shares [1] - Over the past five trading days, there were two days of net increases in holdings by southbound funds, totaling a net increase of 4.909 million shares [1] - In the last twenty trading days, there were eleven days of net increases, with a cumulative net increase of 22.877 million shares [1] Group 2 - As of November 12, 2025, southbound funds hold a total of 1.446 billion shares of Jinxin Reproductive Medicine, representing 52.44% of the company's issued ordinary shares [1] - The trading data shows fluctuations in shareholdings, with a decrease of 0.30% on November 12, 2025, and a previous decrease of 0.07% on November 11, 2025 [2] - The company primarily provides in vitro fertilization (IVF) services and operates in China and the United States, offering a range of reproductive and medical services [2]
锦欣生殖（01951.HK）：11月12日南向资金减持437.5万股